WallStreetZenWallStreetZen

NASDAQ: BVS
Bioventus Inc Stock Ownership - Who owns Bioventus?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Bioventus Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Anthony DadamioSVP General Counsel2025-04-112,958$7.57
$22.39kSell
Katrina J. ChurchSVP Chief Compliance Officer2025-04-111,283$7.57
$9.71kSell
Mark Leonard SingletonSVP CFO2025-04-113,875$7.57
$29.33kSell
Mark Leonard SingletonSVP CFO2025-03-245,479$9.79
$53.64kSell
Anthony DadamioSVP General Counsel2025-03-172,615$9.75
$25.50kSell
Katrina J. ChurchSVP Chief Compliance Officer2025-03-171,018$9.75
$9.93kSell
Anthony DadamioSVP General Counsel2025-02-184,380$10.19
$44.63kSell
Katrina J. ChurchSVP Chief Compliance Officer2025-02-181,537$10.19
$15.66kSell
Mark Leonard SingletonSVP CFO2025-02-186,498$10.19
$66.21kSell
Robert E. ClaypoolePresident and CEO2025-01-1328,786$9.10
$261.95kSell

1 of 2

BVS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BVS insiders and whales buy or sell their stock.

BVS Shareholders

What type of owners hold Bioventus Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Smith Nephew PLC20.00%16,534,814$121.03MInsider
Juniper Investment Company LLC15.93%13,168,697$96.39MInsider
Martin P. Sutter15.85%13,106,565$95.94MInsider
Essex Woodlands Management Inc15.75%13,021,324$95.32MInstitution
Ew Healthcare Partners Acquisition Fund LP15.75%13,021,324$95.32MInsider
John A. Bartholdson8.49%7,018,977$51.38MInsider
Juniper Investment Company LLC8.39%6,939,357$50.80MInstitution
Nantahala Capital Management LLC6.39%5,280,842$38.66MInstitution
Spindletop Healthcare Capital LP4.72%3,906,395$28.59MInsider
David J. Parker3.94%3,255,332$23.83MInsider

1 of 3

BVS vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BVS37.56%62.44%Net Selling
OFIX77.97%22.03%Net BuyingNet Selling
ZIMV85.44%12.44%Net SellingNet Selling
SRDX61.01%38.99%Net Selling
BBNX91.21%8.79%Net BuyingNet Selling
View Top Medical Device Stocks

Bioventus Stock Ownership FAQ

Who owns Bioventus?

Bioventus (NASDAQ: BVS) is owned by 58.46% institutional shareholders, 97.18% Bioventus insiders, and 0.00% retail investors. Smith Nephew PLC is the largest individual Bioventus shareholder, owning 16.53M shares representing 20.00% of the company. Smith Nephew PLC's Bioventus shares are currently valued at $119.22M.

If you're new to stock investing, here's how to buy Bioventus stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.